Papers: 10.1186/s13046-015-0149-2

https://doi.org/10.1186/s13046-015-0149-2

Combined enzyme/prodrug treatment by genetically engineered AT-MSC exerts synergy and inhibits growth of MDA-MB-231 induced lung metastases

Cited by: 31
Author(s): Miroslava Matúšková, Zuzana Kozovská, Lenka Toro, Erika Durinikova, Silvia Tyčiaková, Zuzana Čierna, Roman Bohovic, Lucia Kučerová
Published: over 10 years ago

Software Mentions 1